Diet, gut microbiota, and the gut-brain axis: mechanistic interactions and therapeutic implications in neuropsychiatric disorders
Frontiers in Cellular and Infection Microbiology · 19.06.2026 · 16
DOI: 10.3389/fcimb.2026.1834069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 19.06.2026. Verfasst von Xin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China. Hauptthemen laut MEDLINE: Diet, Gastrointestinal Microbiome, Mental Disorders, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
The gut microbiota is a dynamic trans-kingdom ecosystem that contributes to host immunological, metabolic, and neuroendocrine homeostasis through the microbiota-gut-brain axis (MGBA). Diet is one of the major environmental factors shaping this axis, as it influences microbial composition, microbial production of neuroactive metabolites, and intestinal barrier integrity. Dysbiosis has been increasingly associated with neurological, psychiatric, and neurodevelopmental disorders, including Alzheimer’s disease, Parkinson’s disease, depression, autism spectrum disorder, and attention-deficit/hyperactivity disorder. Experimental studies have identified several potential mechanisms linking gut microbiota to brain function, including immune modulation, vagus nerve signaling, microbial metabolite production, and blood-brain barrier regulation. However, translating these findings into clinical practice remains challenging because human studies are affected by genetic heterogeneity, dietary variation, medication use, lifestyle factors, and disease-specific confounders. In this review, we summarize current evidence on the interactions among diet, gut microbiota, and brain function, with particular emphasis on microbial metabolites, immune mediators, and barrier-related mechanisms. We also critically discuss microbiota-targeted interventions, including precision nutrition, probiotics, and fecal microbiota transplantation, highlighting both their therapeutic potential and their current limitations. A more cautious and mechanistically integrated understanding of the MGBA may support the development of personalized strategies for neuropsychiatric disease prevention and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Department of Otolaryngology-Head and Neck Surgery, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Department of Gynecology, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, X., Piao, Y., Xia, B., Chu, W., Yao, X., & Li, W. (2026). Diet, gut microbiota, and the gut-brain axis: mechanistic interactions and therapeutic implications in neuropsychiatric disorders. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1834069
Vancouver
Wang X, Piao Y, Xia B, Chu W, Yao X, Li W. Diet, gut microbiota, and the gut-brain axis: mechanistic interactions and therapeutic implications in neuropsychiatric disorders. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1834069
BibTeX
@article{Wang2026,
author = {Wang, Xin and Piao, Yinzi and Xia, Baoguo and Chu, Weixin and Yao, Xiaohua and Li, Weisheng},
title = {Diet, gut microbiota, and the gut-brain axis: mechanistic interactions and therapeutic implications in neuropsychiatric disorders},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1834069}
}
EUVIMED